Are you referring to a clinical hold? The company has not confirmed to the market that PAR is in a clinical hold and if they were then the FDA is obligated to notify PAR of this in writing soon after the phone call along with their concerns, and I would imagine PAR would also have to notify the market.
It appears the FDA simply needs time to ask questions outside the 30-day period.
We'll find out next week.
Ann: PARADIGM ACHIEVES FIRST REVENUE, page-21
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |